Comparative Pharmacology
Head-to-head clinical analysis: PROMETH FORTIS versus TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES W CODEINE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PROMETH FORTIS versus TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES W CODEINE.
PROMETH FORTIS vs TRIPROLIDINE AND PSEUDOEPHEDRINE HYDROCHLORIDES W/ CODEINE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Promethazine is a phenothiazine derivative that acts as a histamine H1 receptor antagonist, with additional anticholinergic, antiemetic, and sedative properties. It blocks histamine at H1 receptors, reducing allergic symptoms and motion sickness, and exerts antiemetic effects by blocking dopamine D2 receptors in the chemoreceptor trigger zone.
Codeine is a prodrug converted to morphine, a mu-opioid receptor agonist, producing analgesia and antitussive effects. Triprolidine is a first-generation antihistamine blocking H1 receptors, reducing histamine effects. Pseudoephedrine is a sympathomimetic amine acting as a decongestant via alpha-adrenergic receptor agonism in respiratory tract mucosa.
Adults: 12.5-25 mg intramuscular or intravenous every 4-6 hours as needed for nausea. For severe nausea up to 50 mg IM/IV. Maximum single dose 50 mg, maximum daily dose 200 mg.
Oral: 1 tablet (triprolidine 2.5 mg, pseudoephedrine 60 mg, codeine 30 mg) every 4-6 hours as needed; maximum 4 tablets per day.
None Documented
None Documented
Terminal elimination half-life: 9–16 hours (mean ~12 hours). In children and elderly, half-life may be prolonged (up to 20 hours).
Codeine: 2.5-3.5 hours; clinical context: short half-life necessitates frequent dosing. Triprolidine: 3-5 hours; clinical context: typical dosing every 4-6 hours. Pseudoephedrine: 5-8 hours (alkaline urine prolongs to ~10-13 hours); clinical context: extended-release formulations available.
Primarily renal as inactive metabolites; <1% excreted unchanged. Total elimination: renal ~70%, fecal ~30%.
Codeine: renal elimination of metabolites (primarily codeine-6-glucuronide, norcodeine, and morphine glucuronides); approximately 90% excreted renally, with about 10% as unchanged codeine. Triprolidine: renal elimination (80-90% as metabolites, <5% unchanged). Pseudoephedrine: renal elimination (70-90% unchanged, dependent on urine pH).
Category C
Category A/B
Antihistamine
Antihistamine